Glucose transport hereditary diseases;Síndromes hereditarios del transporte de glucosa

Medicina Clinica

Volumn 127, Issue 18, 2006, Pages 709-714

  Pascual, Juan M ^a,b  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Epilepsy; Fanconi Bickel syndrome; Glucose; Glucose galactose malabsorption; GLUT1 deficiency syndrome; Hypoglycorrhachia; Ketogenic diet

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 3; GLUCOSE TRANSPORTER 1;

BRAIN; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISORDERS OF CARBOHYDRATE METABOLISM; EPILEPSY; FANCONI RENOTUBULAR SYNDROME; GENE MUTATION; GENETIC DISORDER; GLUCOSE GALACTOSE MALABSORPTION; GLUCOSE TRANSPORT; GLUCOSE TRANSPORTER 1 DEFICIENCY SYNDROME; HUMAN; INTESTINE; LIVER; MALABSORPTION; METABOLIC DISORDER; PATHOPHYSIOLOGY; PROTEIN DEFICIENCY; REVIEW;

EID: 33845994709     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13095099     Document Type: Review

References (50)

1. Cahill GJ Jr, Owen OE, Morgan AP. The consumption of fuels during prolonged starvation. Adv Enzyme Regul. 1968;6:143-50.
2. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr. Brain metabolism during fasting. J Clin Invest. 1967;46:1589-95.
3. Longo N, Elsas LJ. Human glucose transporters. Adv Pediatr. 1998; 45:293-313.
4. Uldry M, Thorens B. The SLC2 family of facilitated hexose and polyol transporters. Pflugers Arch. 2004;447:480-9.
5. Wood IS, Trayhurn P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr. 2003;89:3-9.
6. Hediger MA, Ikeda T, Coady M, Gundersen CB, Wright EM. Expression of size-selected mRNA encoding the intestinal Na/glucose cotransporter in Xenopus laevis oocytes. Proc Natl Acad Sci USA. 1987;84:2634-7.
7. Burchell A. A re-evaluation of GLUT 7. Biochem J. 1998;331 (Pt 3):973.
8. Ransom BR, Fern R. Does astrocytic glycogen benefit axon function and survival in CNS white matter during glucose deprivation? Glia. 1997;21: 134-41.
9. De Vivo DC, Pascual JM, Wang D. Glucose transporter type I deficiency syndrome. En: Rowland LP, editor. Merritt's neurology. 11th ed. Philadelphia: Lippincott; 2005. p. 644-6.
10. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. Energy on demand. Science. 1999;283:496-7.
11. Pellerin L, Magistretti PJ. Neuroenergetics: calling upon astrocytes to satisfy hungry neurons. Neuroscientist. 2004;10:53-62.
12. McKusick VA. Mendelian Inheritance in Man. A catalog of human genes and genetic disorders. 12th ed. Baltimore: Johns Hopkins University Press; 1998. [Versión actualizada en Internet: Online Mendelian Inheritance in Man, OMIM™. McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD); 2000. Disponible en: www.ncbi.nlm.nih.gov/omim]
13. Lindquist B, Meeuwisse G. Chronic diarrhoea caused by monosaccharide malabsorption. Acta Paediatr. 1962;51:674-85.
14. Laplane R, Polonovski C, Etienne M, Debray P, Lods J, Passrro B. L'inttolerance aux sucres a transfert intestinal actif. Arch Fr Pediatr. 1962; 19:895-944.
15. Turk E, Zabel B, Mundlos S, Dyer J, Wright EM. Glucose/galactose malabsorption caused by a defect in the Na+/glucose cotransporter. Nature. 1991;350:354-6.
16. Wright EM, Turk E, Martin MG. Molecular basis for glucose-galactose malabsorption. Cell Biochem Biophys. 2002;36:115-21.
17. Fanconi G, Bickel H. Die chronische aminoacidurie (Aminosaeurediabetes oder nephrotisch-glukosurisscher Zwergwuchs) ber der Glykogenose und Cystinkrankheit. Helv Paediat Acta. 1949;4:359-96.
18. Santer R, Schneppenheim R, Suter D, Schaub J, Steinmann B. Fanconi-Bickel syndrome - the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature. Eur J Pediatr. 1998;157:783-97.
19. Santer R, Groth S, Kinner M, Dombrowski A, Berry GT, Brodehl J, et al. The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome. Hum Genet. 2002;110:21-9.
20. Santer R, Steinmann B, Schaub J. Fanconi-Bickel syndrome - a congenital defect of facilitative glucose transport. Curr Mol Med. 2002;2: 213-27.
21. De Vivo D, Lackie M, Ferrendelli J, McDougal D. Chronic ketosis and cerebral metabolism. Ann Neurol. 1978;3:331-7.
22. De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med. 1991;325:703-9.
23. De Vivo DC, García-Álvarez M, Ronen GM, Behmand RA, Trifiletti RR. Glucose transport protein deficiency: an emerging syndrome with therapeutic implications. Int Pediatr. 1995;10:51-6.
24. De Vivo D, Wang D, Pascual JM. Disorders of glucose transport. En: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, Nestler EJ, editors. The molecular and genetic basis of neurologic and psychiatric disease. 3rd ed. Philadelphia: Butterworth-Heinemann; 2003. p. 625-34.
25. Pascual JM, Wang D, Lecumberri B, Yang H, Mao X, Yang R, et al. GLUT1 deficiency and other glucose transporter diseases. Eur J Endocrinol. 2004;150:627-33.
26. Pascual JM, Wang, D, De Vivo, DC. Glucose transporter type 1 deficiency syndrome. En: De Vivo disease: GeneReviews. Disponible en: www.geneclinics.org
27. Leary LD, Wang D, Nordli DR Jr, Engelstad K, De Vivo DC. Seizure characterization and eiectroencephalographic features in Glut-1 deficiency syndrome. Epilepsia. 2003;44:701-7.
28. Brockmann K, Wang D, Korenke CG, Von Moers A, Ho YY, Pascual JM, et al. Autosomal dominant glut-1 deficiency syndrome and familial epilepsy. Ann Neurol. 2001;50:476-85.
29. Wang D, Pascual JM, Yang H, Engelstad K, Jhung S, Sun RP, et al. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol. 2005;57:111-8.
30. De Vivo DC, Wang D, Pascual JM, Ho Y-Y. Glucose transporter protein deficiency syndromes. En: Dwyer DS, editor. Glucose metabolism in the Brain. Int Rev Neurobiol. San Diego: Academic Press; 2002. p. 259-88.
31. Ho Y-Y, Wang D, De Vivo D. Glucose transporters. Wiley Encyclopedia of Molecular Medicine. 2001;5:1441-6.
32. Chugani HT, Phelps ME. Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography. Science. 1986;231:840-3.
33. Iserovich P, Wang D, Ma L, Yang H, Zuniga FA, Pascual JM, et al. Changes in glucose transport and water permeability resulting from the T310I pathogenic mutation in Glut1 are consistent with two transport channels per monomer. J Biol Chem. 2002;277:30991-7.
34. Klepper J, Vera JC, De Vivo DC. Deficient transport of dehydroascorbic acid in the glucose transporter protein syndrome. Ann Neurol. 1998; 44:286-7.
35. Abramson J, Smirnova I, Kasho V, Verner G, Kaback HR, Iwata S. Structure and mechanism of the lactose permease of Escherichia coli. Science. 2003;301:610-5.
36. Abramson J, Kaback HR, Iwata S. Structural comparison of lactose permease and the glycerol-3-phosphate antiporter: members of the major facilitator superfamily. Curr Opin Struct Biol. 2004;14:413-9.
37. Guan L, Kaback HR. Lessons from lactose permease. Annu Rev Biophys Biomol Struct. 2005;35:67-91.
38. Klepper J, García-Álvarez M, O'Driscoll KR, Parides MK, Wang D, Ho YY, et al. Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose-transporter-protein syndrome. J Clin Lab Anal. 1999;13:116-21.
39. Pascual JM, Van Heertum RL, Wang D, Engelstad K, De Vivo DC. Imaging the metabolic footprint of Glut1 deficiency on the brain. Ann Neurol. 2002;52:458-64.
40. Wang D, Kranz-Eble P, De Vivo DC. Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome. Hum Mutat. 2000;16:224-31.
41. Seidner G, Álvarez MG, Yeh JI, O'Driscoll KR, Klepper J, Stump TS, et al. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet. 1998;18:188-91.
42. De Vivo DC. The effects of ketone bodies on glucose utilization. En: Passonneau JV, Hawkins RA, Lust RA, Welsh FA, editors. Cerebral metabolism and neural function. Baltimore: Williams & Wilkins; 1980. p. 243-54.
43. Khamaisi M, Potashnik R, Tirosh A, Demshchak E, Rudich A, Tritschler H, et al. Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats. Metabolism. 1997;46:763-8.
44. Kulikova-Schupak R, Ho YY, Kranz-Eble P, Yang H, Wang D, De Vivo DC. Stimulation of GLUT-1 gene transcription by thioctic acid and its potential therapeutic value in Glut-1 deficiency syndrome (GLUT-1DS). J Inherit Metab Dis. 2001;24:S106.
45. Klepper J, Fischbarg J, Vera JC, Wang D, De Vivo DC. GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitro. Pediatr Res. 1999;46:677-83.
46. Ho YY, Yang H, Klepper J, Fischbarg J, Wang D, De Vivo DC. Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitro. Pediatr Res. 2001;50:254-60.
47. St-Denis JF, Cushman SW. Role of SNARE'S in the GLUT4 translocation response to insulin in adipose cells and muscle. J Basic Clin Physiol Pharmacol. 1998;9:153-65.
48. Rice JE, Livingstone C, Gould GW. Trafficking, targeting and translocation of the insulin-responsive glucose transporter, GLUT4, in adipocytes. Biochem Soc Trans. 1996;24:540-6.
49. Mueckler M, Kruse M, Strube M, Riggs AC, Chiu KC, Permutt MA. A mutation in the Glut2 glucose transporter gene of a diabetic patient abolishes transport activity. J Biol Chem. 1994;269:17765-7.
50. McVie-Wylie AJ, Lamson DR, Chen YT. Molecular cloning of a novel member of the GLUT family of transporters, SLC2a10 (GLUT10), localized on chromosome 20q13.1: a candidate gene for NIDDM susceptibility. Genomics. 2201;72:113-7.